NDC00002-7278-25 by Eli Lilly And Company - Receive a Competitive Quote
| Part Number: NDC00002-7278-25 | Alternate P/N: NDC00002727825 | Manufacturer: Eli Lilly And Company | NSN : 6505-01-270-0399 | Item Name : Cefuroxime Sodium U | CAGE Code: 75602 | ||
We’re excited to announce that NDC00002-7278-25 NSN part is now available and ready for immediate shipping. Part number NDC00002-7278-25 is a Cefuroxime Sodium U manufactured by Eli Lilly And Company with NSN 6505012700399. Are you interested in a quick and competitive quote for this part?
Just NSN Parts, owned and operated by ASAP Semiconductor, is a leading distributor of NSN (National Stock Number) parts, new and obsolete. Because of our dedication to quality, we’re the only independent distributor in the United States with a strict No China Sourcing Pledge. We’re also an AS9120B, ISO 9001:2015 certified, and FAA AC 0056B accredited member of the Aviation Suppliers Association (ASA). Our vast and comprehensive inventory of over 2 billion parts coupled with our shipping facilities in Washington, Oregon, California, New Maxico, Nevada, Arizona, Illinois, Minnesota, Pennsylvania, and New York, allow us to offer you some of the fastest delivery times in the industry.
If you’d like to learn more about NSN part number NDC00002-7278-25 Cefuroxime Sodium U, feel free to call us at our toll-free number, +1-714-705-4780, or email us at sales@justnsnparts.com. And, if you’d like to stay informed on new inventory or any promotions, feel free to download the ASAP Semiconductor App from Google Play or the App Store.
NSN Information for Part Number NDC00002-7278-25 with NSN 6505-01-270-0399, 6505012700399
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-270-0399 Item Description: Cefuroxime Sodium U | 6505 | 012700399 | M | Y | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| Ndc00002-7278-25 | 2 | 3 |
Characteristics Data of NSN 6505-01-270-0399, 6505012700399
| MRC | Criteria | Characteristic |
|---|---|---|
| AGXW | PHYSICAL FORM | POWDER |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| FEAT | SPECIAL FEATURES | IN 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION; 6505-01-260-1237; 6505-01-260-1238; 6505-01-260-1239 AND SODIUM CHLORIDE INJECTION; 6505-01-260-1241; 6505-01-260-1242; AND 6505-01-260-6715; EACH VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 750.000 MILLIGRAMS OF ACTIVE INGREDIENT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFUROXIME SODIUM STERILE POWDER FORM 750MG VIAL 25S |
